XTX Topco’s Latigo Biotherapeutics LTGO Stock Holding History
Bought
Maintained
Sold
Other funds holding LTGO
XTX Topco's LTGO Position: Q3 2026 in Review
XTX Topco opened a new position in Latigo Biotherapeutics (LTGO) in Q3 2026: 13,238 shares worth $221K. The stake represents ﹤0.01% of the portfolio and ranks #3042 among its holdings.
58 funds tracked by Wall St. Rank hold LTGO as of Q3 2026.
- XTX Topco held 13,238 shares of Latigo Biotherapeutics worth $221K as of Q3 2026.
- Latigo Biotherapeutics was a new XTX Topco position in Q3 2026.
- Latigo Biotherapeutics made up ﹤0.01% of XTX Topco's portfolio in Q3 2026, its #3042 holding.
- 58 funds tracked by Wall St. Rank held Latigo Biotherapeutics as of Q3 2026.
Based on XTX Topco's 13F filing for Q3 2026, filed 16 Nov 2026.